Roots
Analysis is pleased to announce the publication of its recent study, titled, “Next Generation Immune Checkpoint
Inhibitors and Stimulators Market,
2020-2030.” 

The
report features an extensive study of the current market landscape, offering an
informed opinion on the likely adoption of these therapies over the next
decade. It features an in-depth analysis, highlighting the capabilities of
various stakeholders engaged in this domain. In addition to other elements, the
study includes:

·       
A detailed assessment of the current market
landscape of drug developers engaged in the development of next generation
immune checkpoint modulators.

·       
A detailed analysis of more than 590
completed, ongoing and planned clinical studies of next generation immune
checkpoint inhibitors and stimulators.

·       
Detailed profiles of developers of next
generation immune checkpoint modulators (shortlisted on the basis of the number
of pipeline products).

·       
An in-depth analysis of more than 490 grants
that have been awarded to research institutes engaged in next generation immune
checkpoint therapy-related projects.

·       
An analysis of the partnerships that have
been established in this domain, in the recent past.

·       
A competitiveness analysis of biological
targets, featuring insightful pictorial summaries and representations.

·       
An analysis of the initiatives of big
biopharma players engaged in this domain.

A
detailed market forecast, featuring analysis of the current and projected
future opportunity across key market segments (listed below)